<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24884895</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><PubDate><Year>2014</Year><Month>May</Month><Day>27</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>Concentration and purification of enterovirus 71 using a weak anion-exchange monolithic column.</ArticleTitle><Pagination><StartPage>99</StartPage><MedlinePgn>99</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1743-422X-11-99</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Enterovirus 71 (EV-71) is a neurotropic virus causing Hand, Foot and Mouth Disease (HFMD) in infants and children under the age of five. It is a major concern for public health issues across Asia-Pacific region. The most effective way to control the disease caused by EV-71 is by vaccination thus a novel vaccine is urgently needed. Inactivated EV-71 induces a strong, virus-neutralizing antibody response in animal models, protecting them against a lethal EV-71 challenge and it has been shown to elicit cross-neutralizing antibodies in human trials. Hence, the large-scale production of purified EV-71 is required for vaccine development, diagnosis and clinical trials.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">CIM&#xae; Monolith columns are single-piece columns made up of poly(glycidyl methacrylate co-ethylene dimethacrylate) as support matrix. They are designed as porous channels rather than beads with different chemistries for different requirements. As monolithic columns have a high binding capacity, flow rate and resolution, a CIM&#xae; DEAE-8f tube monolithic column was selected for purification in this study. The EV-71 infected Rhabdomyosarcoma (RD) cell supernatant was concentrated using 8% PEG 8000 in the presence of 400&#xa0;mM sodium chloride. The concentrated virus was purified by weak anion exchange column using 50&#xa0;mM HEPES&#x2009;+&#x2009;1&#xa0;M sodium chloride as elution buffer.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Highly pure viral particles were obtained at a concentration of 350&#xa0;mM sodium chloride as confirmed by SDS-PAGE and electron microscopy. Presence of viral proteins VP1, VP2 and VP3 was validated by western blotting. The overall process achieved a recovery of 55%.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">EV-71 viral particles of up to 95% purity can be recovered by a single step ion-exchange chromatography using CIM-DEAE monolithic columns and 1&#xa0;M sodium chloride as elution buffer. Moreover, this method is scalable to purify several litres of virus-containing supernatant, using industrial monolithic columns with a capacity of up to 8&#xa0;L such as CIM&#xae; cGMP tube monolithic columns.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kattur Venkatachalam</LastName><ForeName>Ashok Raj</ForeName><Initials>AR</Initials></Author><Author ValidYN="Y"><LastName>Szyporta</LastName><ForeName>Milene</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Kiener</LastName><ForeName>Tanja Kristin</ForeName><Initials>TK</Initials></Author><Author ValidYN="Y"><LastName>Balraj</LastName><ForeName>Premanand</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Kwang</LastName><ForeName>Jimmy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Animal Health Biotechnology, Temasek Lifesciences Laboratory, National University of Singapore, Singapore 117604, Singapore. kwang@tll.org.sg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002852" MajorTopicYN="N">Chromatography, Ion Exchange</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014773" MajorTopicYN="N">Virology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>5</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24884895</ArticleId><ArticleId IdType="pmc">PMC4042139</ArticleId><ArticleId IdType="doi">10.1186/1743-422X-11-99</ArticleId><ArticleId IdType="pii">1743-422X-11-99</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974;129:304&#x2013;309. doi: 10.1093/infdis/129.3.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi M-H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10:778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou A-H, Liu C-C, Chang C-P, Guo M-S, Hsieh S-Y, Yang W-H, Chao H-J, Wu C-L, Huang J-L, Lee M-S, Hu AY-C, Lin S-C, Huang Y-Y, Hu M-H, Chow Y-H, Chiang J-R, Chang J-Y, Chong P. Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates. PLoS ONE. 2012;7(4):e34834. doi: 10.1371/journal.pone.0034834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034834</ArticleId><ArticleId IdType="pmc">PMC3328501</ArticleId><ArticleId IdType="pubmed">22529942</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y-P, Liang Z-L, Gao Q, Huang L-R, Mao Q-Y, Wen S-Q, Liu Y, Yin W-D, Li R-C, Wang J-Z. Safety and immunogenicity of a novel human Enterovirus 71 (EV-71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial. Vaccine. 2012;30(22):3295&#x2013;3303. doi: 10.1016/j.vaccine.2012.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.03.010</ArticleId><ArticleId IdType="pubmed">22426327</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J, Chang C, Tsai HH, Lee C, Lian W, Ih-Jen-Su, Sai I, Liu C, Chou A, Lu Y, Chen C, Lee P, Chiang J, Chong PC. Selection and characterization of vaccine strain for enterovirus 71 vaccine development. Vaccine. 2012;30:703&#x2013;711. doi: 10.1016/j.vaccine.2011.11.087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.11.087</ArticleId><ArticleId IdType="pubmed">22142585</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Dong C, Li X, Gao Q, Guo Z, Yao X, Wang Y, Gao F, Li F, Xu M, Yin W, Li Q, Shen X, Liang Z, Wang J. Comparative analysis of the immunogenicity and protective effects of inactivated EV-71 vaccines in mice. PLoS ONE. 2012;7(9):e46043. doi: 10.1371/journal.pone.0046043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0046043</ArticleId><ArticleId IdType="pmc">PMC3460965</ArticleId><ArticleId IdType="pubmed">23029378</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng FY, Li JX, Li XL, Chu K, Zhang YT, Ji H, Li L, Liang ZL, Zhu FC. Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy and adults and children: an open label, phase 1 clinical trial. Hum Vaccin Immunother. 2012;8:668&#x2013;674. doi: 10.4161/hv.19521.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.19521</ArticleId><ArticleId IdType="pubmed">22634437</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagnon P. Chromatographic Purification of Virus Particles. Industrial Biotechnology: Encyclopedia of; 2009. pp. 1&#x2013;21.</Citation></Reference><Reference><Citation>Sim S-L, He T, Tscheliessnig A, Mueller M, Tan RBH, Jungbauer A. Protein precipitation by polyethylene glycol: a generalized model based on hydrodynamic radius. J Biotechnol. 2012;157:315&#x2013;319. doi: 10.1016/j.jbiotec.2011.09.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbiotec.2011.09.028</ArticleId><ArticleId IdType="pubmed">22001847</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingham KC. Precipitation of proteins with polyethylene glycol. Methods Enzymol. 1990;182:301&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">2314243</ArticleId></ArticleIdList></Reference><Reference><Citation>Magar R, Lecomte J. Comparison of methods for concentration and purification of bovine viral diarrhoea virus. J Virol Methods. 1987;16:271&#x2013;279. doi: 10.1016/0166-0934(87)90012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-0934(87)90012-7</ArticleId><ArticleId IdType="pubmed">2822746</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K, Wen Z, Li N, Yang W, Hu L, Wang J, Yin Z, Dong X, Li J. Purification and concentration of mycobacteriophage D29 using monolithic chromatographic columns. J Virol Methods. 2012;186:7&#x2013;13. doi: 10.1016/j.jviromet.2012.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2012.07.016</ArticleId><ArticleId IdType="pubmed">22820071</ArticleId></ArticleIdList></Reference><Reference><Citation>Podgornik A, Yamamoto S, Peterka M, Krajnc NL. Fast separation of large biomolecules using short monolithic columns. J Chromatogr B. 2013;927:80&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">23465515</ArticleId></ArticleIdList></Reference><Reference><Citation>Segura MM, Puig M, Monfar M, Chillon M. Chromatography purification of canine adenoviral vectors. Hum Gene Ther Methods. 2012;23(3):182&#x2013;197. doi: 10.1089/hgtb.2012.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hgtb.2012.058</ArticleId><ArticleId IdType="pubmed">22799886</ArticleId></ArticleIdList></Reference><Reference><Citation>Adriaenssens EM, Lehman SM, van der Steegen K, van den Heuvel D, Philippe DL, Cornelissen A, Clokie MRJ, Garcia AJ, De Proft M, Maes M, Lavigne R. CIM&#xae; monolithic anion-exchange chromatography as a useful alternative to CsCl gradient purification of bacteriophage particles. Virology. 2012;434(2):265&#x2013;270. doi: 10.1016/j.virol.2012.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2012.09.018</ArticleId><ArticleId IdType="pmc">PMC4286298</ArticleId><ArticleId IdType="pubmed">23079104</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramberger P, Peterka M, Boben J, Ravnikar M, Strancar A. Short monolithic columns &#x2013; a breakthrough in purification and fast quantification of tomato mosaic virus. J Chromatogr A. 2007;1144(1):143&#x2013;149. doi: 10.1016/j.chroma.2006.10.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chroma.2006.10.055</ArticleId><ArticleId IdType="pubmed">17097098</ArticleId></ArticleIdList></Reference><Reference><Citation>Rupar M, Ravnikar M, Tu&#x161;ek-&#x17d;nidari&#x10d; M, Kramberger P, Glais L, Guti&#xe9;rrez-Aguirre I. Fast purification of the filamentous Potato virus Y using monolithic chromatographic supports. J Chromatogr A. 2013;1272:33&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">23253119</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofer GK, Nystr&#xf6;m LE. Process Chromatography. A Practical Guide. London: Academic Press; 1989.</Citation></Reference><Reference><Citation>Vidi&#x10d; J, Podgornik A, Jan&#x10d;ar J, Frankovi&#x10d; V, Ko&#x161;ir B, Lendero N, &#x10c;u&#x10d;ek K, Krajnc M, &#x160;tramcar A. Chemical and chromatographic stability of methacrylate-based monolithic columns. J Chromatogr A. 2007;1144(1):63&#x2013;71. doi: 10.1016/j.chroma.2006.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chroma.2006.11.030</ArticleId><ArticleId IdType="pubmed">17141793</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalashnikova I, Ivanova N, Tennikova T. Development of a strategy of influenza virus separation based on pseudoaffinity chromatography on short monolithic columns. Anal Chem. 2008;80:2188&#x2013;2198. doi: 10.1021/ac702258t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac702258t</ArticleId><ArticleId IdType="pubmed">18271603</ArticleId></ArticleIdList></Reference><Reference><Citation>Segura MM, Kamen AA, Garnier A. In: Viral Vectors for Gene Therapy: Methods and Protocols. Merten O-W, Al-Rubeai M, editor. New Jersey: Springer Protocols; 2011. Overview of current scalable methods for purification of viral vectors; pp. 89&#x2013;116. [Methods in Molecular Biology, vol. 737]</Citation><ArticleIdList><ArticleId IdType="pubmed">21590394</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg. 1938;27:493&#x2013;497.</Citation></Reference><Reference><Citation>Lim XF, Jia Q, Khong WX, Yan B, Premanand B, Alonso S, Chow VTK, Kwang J. Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection. PLoS ONE. 2012;7(1):e29751. doi: 10.1371/journal.pone.0029751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0029751</ArticleId><ArticleId IdType="pmc">PMC3261156</ArticleId><ArticleId IdType="pubmed">22279543</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiener TK, Jia Q, Lim XF, He F, Meng T, Chow VTK, Kwang J. Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein. Virol J. 2012;9:55. doi: 10.1186/1743-422X-9-55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-55</ArticleId><ArticleId IdType="pmc">PMC3307493</ArticleId><ArticleId IdType="pubmed">22361222</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummeler K. Identification of poliovirus particles of different antigenicity by specific agglutination as seen in the electron microscope. Virology. 1962;16:84&#x2013;90. doi: 10.1016/0042-6822(62)90205-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(62)90205-2</ArticleId><ArticleId IdType="pubmed">14449962</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002;26:91&#x2013;107. doi: 10.1111/j.1574-6976.2002.tb00601.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C-C, Guo M-S, Lin FH-Y, Hsiao K-N, Chang KH-W, Chou A-H, Wang Y-C, Chen Y-C, Yang C-S, Chong PC-S. Purification and characterization of enterovirus 71 viral particles produced from Vero cells grown in a serum-free microcarrier bioreactor system. PLoS ONE. 2011;6(5):e20005. doi: 10.1371/journal.pone.0020005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020005</ArticleId><ArticleId IdType="pmc">PMC3094384</ArticleId><ArticleId IdType="pubmed">21603631</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C-C, Chang H-W, Yang G, Chiang J-R, Chow Y-H, Sai I-H, Chang J-Y, Lin S-C, Sia C, Hsiao C-H, Chou A-H, Chong P. Development of a quantitative enzyme linked immunosorbent assay for monitoring the enterovirus 71 vaccine manufacturing process. J Virol Methods. 2011;176:60&#x2013;68. doi: 10.1016/j.jviromet.2011.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2011.06.001</ArticleId><ArticleId IdType="pubmed">21704080</ArticleId></ArticleIdList></Reference><Reference><Citation>Podgornik A, Nika Lendero Krajnc NL. Application of monoliths for bioparticle isolation. J Sep Sci. 2012;35:3059&#x2013;3072. doi: 10.1002/jssc.201200387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jssc.201200387</ArticleId><ArticleId IdType="pubmed">23111905</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramberger P, Petrovi&#x10d; N, &#x160;trancar A, Ravnikar M. Concentration of plant viruses using monolithic chromatographic supports. J Virol Methods. 2004;120:51&#x2013;57. doi: 10.1016/j.jviromet.2004.03.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2004.03.018</ArticleId><ArticleId IdType="pubmed">15234809</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceyssens PJ, Noben JP, Ackermann HW, Verhaegen J, DeVos D, Pirnay JP, Merabishvili M, Vaneechoutte M, Chibeu A, Volckaert G, Lavigne R. Survey of pseudomonas aeruginosa and its phages: denovo peptide sequencing as a novel tool to assess the diversity of worldwide collected viruses. Environ Microbiol. 2009;11:1303&#x2013;1313. doi: 10.1111/j.1462-2920.2008.01862.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-2920.2008.01862.x</ArticleId><ArticleId IdType="pubmed">19207572</ArticleId></ArticleIdList></Reference><Reference><Citation>Forcic D, Brgles M, Ivancic-Jelecki J, Santak M, Halassy B, Barut M, Jug R, Marku&#x161;i&#x107; M, Strancar A. Concentration and purification of rubella virus using monolithic chromatographic support. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879(13&#x2013;14):981&#x2013;986.</Citation><ArticleIdList><ArticleId IdType="pubmed">21440513</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandersteegen K, Mattheus W, Ceyssens PJ, Bilocq F, DeVos D, Pirnay JP, Noben JP, Merabishvili M, Lipinska U, Hermans K, Lavigne R. Microbiological and molecular assessment of bacteriophage ISP for the control of staphylococcus aureus. PLoS ONE. 2011;6:e24418. doi: 10.1371/journal.pone.0024418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0024418</ArticleId><ArticleId IdType="pmc">PMC3170307</ArticleId><ArticleId IdType="pubmed">21931710</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandeira V, Peixoto C, Rodrigues AF, Cruz PE, Alves PM, Coroadinha AS, Carrondo MJ. Downstream processing of lentiviral vectors: releasing bottlenecks. Hum Gene Ther Methods. 2012;23(4):255&#x2013;263. doi: 10.1089/hgtb.2012.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hgtb.2012.059</ArticleId><ArticleId IdType="pubmed">22934827</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C-C, Chou A-H, Lien S-P, Lin H-Y, Liu S-J, Chang J-Y, Guo M-S, Chow Y-H, Yang W-S, Chang KH-W, Sia C, Chong P. Identification and characterization of a cross-neutralization epitope of enterovirus 71. Vaccine. 2011;29:4362&#x2013;4372. doi: 10.1016/j.vaccine.2011.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.04.010</ArticleId><ArticleId IdType="pubmed">21501643</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>